CURICT - Information and Communication Technologies Use in patients with Chronic Spontaneous and Chronic inducible Urticaria (CURICOT, chronic urticaria – patient use of information and communication technologies)

    New strategies to improve clinical outcomes, adherence and encourage communication between health-care providers and patients are nowadays being explored, giving rise to a heightened interest in the use of information and communication technologies (ICTs) for medical purposes. CURICT aims to assess the frequency and preference of ICTs use in patients with chronic spontaneous and chronic inducible urticaria. 

    Study type: Questionnaire

    The study results will be presented at an international congress (preferably at the EADV or EAACI) and they will be submitted for publication, e.g. in ALLERGY. To become a coauthor, you need to include at least 10 patients to the study and contribute to the interpretation of the results and the development of the manuscript. The sequence of coauthors, in authors who contributed equally to data interpretation and manuscript development will be based on the number of patients included. 

    Deadline: A30.06.2019

    Are you interested in joining this study? Please visit our member’s are or send an Email to curict.ucareproject@gmail.com for additional information. 

    Courage&Khazaka has announced that TempTest® is available again

    Read more

    5th GA²LEN Global Urticaria Forum (GUF 2020) and 6th Consensus Conference on the Update and Revision of the international EAACI/GA²LEN/EuroGuiDerm/APAAACI Guideline for Urticaria

    Read more

    One of Allergy’s goals is to disseminate your research and expand the readership of your important data. As such, we have created a YouTube channel promoting the articles published in our journal.

    Read more

    Contact us

    GA²LEN coordinating Office
    c/o DGAKI
    Robert-Koch-Platz 7
    10115 Berlin, Germany

    UCARE office
    Laura Schwenner

    info(at)ga2len-ucare.com